Henry Rosevear, MD, talks about how he and his practice are coping with the COVID-19 pandemic.
Henry Rosevear, MD, Urology Times® Clinical Practice Board member and blogger, has written thoughtfully and eloquently about the COVID-19 pandemic in recent blog posts for UrologyTimes.com. Urology Times® spoke to him on April 7 about how he and his practice are coping with the present situation. Also see: COVID-19 and urology: What you can do How ‘elective’ surgery is defined during the COVID-19 crisis Telemedicine in urology: A crash course during the COVID-19 pandemic
New prognostic factors identified for testicular seminoma relapse
September 29th 2023About 1 of every 5 patients with stage I seminoma relapses; however, “the level of evidence supporting the use of currently defined risk factors in decision making is low,” wrote lead author Thomas Wagner, MD, and coinvestigators.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
2 Clarke Drive
Cranbury, NJ 08512